Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.58 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.53 |
| ▸ | CPB1 | P15086 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluoride SCHEMBL28811107 | 0.98 | ALDH1A1 (0.56) | ALDH1A1NPSR1KMT2AMAPTKDM4E | |
| SCHEMBL12615992 | 0.85 | ALDH1A1 (0.68) | ALDH1A1NPSR1KMT2AMAPTKDM4E | |
| SCHEMBL18378771 | 0.85 | ALDH1A1 (0.54) | ALDH1A1NPSR1KMT2AMAPTKDM4E | |
| SCHEMBL15786407 | 0.77 | KMT2A (0.66) | ALDH1A1NPSR1KMT2AMAPTKDM4E | |
| SCHEMBL17518817 | 0.77 | KMT2A (0.61) | ALDH1A1NPSR1KMT2AMAPTKDM4E | |
| SCHEMBL16144650 | 0.77 | ALDH1A1 (0.54) | ALDH1A1NPSR1KMT2AKDM4ENOTUM | |
| SCHEMBL8540440 | 0.76 | ALDH1A1 (0.58) | ALDH1A1NPSR1KMT2AMAPTKDM4E | |
| SCHEMBL14242848 | 0.76 | ALDH1A1 (0.58) | ALDH1A1NPSR1KMT2AMAPTKDM4E | |
| SCHEMBL5549180 | 0.76 | ALDH1A1 (0.58) | ALDH1A1NPSR1KMT2AMAPTKDM4E | |
| SCHEMBL30084182 | 0.76 | ALDH1A1 (0.58) | ALDH1A1NPSR1KMT2AMAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2200562-B1 | DENTAL COMPOSITION FOR DETECTING BACTERIA, KIT OF PARTS AND USE THEREOF | 3M INNOVATIVE PROPERTIES CO (US) | 2014-04-23 | — | — | EP | claimed |
| EP-1294922-B1 | TREATING CANCER USING ORGANELLE CRYSTALLIZING AGENTS | KONG QINGZHONG (CN) | 2010-04-14 | — | — | EP | claimed |
| US-7524872-B2 | Method and composition for treating cancer using cellular organelle crystallizing agents | KONG QINGZHONG | 2009-04-28 | — | — | US | claimed |
| US-20080166753-A1 | Microbial Growth Assay | UNIVERSITY TECHNOLOGIES INTERNATIONAL INC. (CA) | 2008-07-10 | — | — | US | claimed |
| US-20060286170-A1 | Method and composition for treating cancer using cellular organelle crystallizing agents | KONG QINGZHONG | 2006-12-21 | — | — | US | claimed |
| US-7102011-B2 | Methods and compositions for the visualization of cellular organelles using tetrazolium salts | KONG QINGZHONG | 2006-09-05 | — | — | US | claimed |
| WO-2005098023-A1 | MICROBIAL GROWTH ASSAY | UNIVERSITY TECHNOLOGIES INTERNATIONAL INC. (CA) | 2005-10-20 | — | — | WO | claimed |
| US-6864272-B2 | Method and composition for treating cancer using cellular organelle crystallizing agents | KONG QINGZHONG (US) | 2005-03-08 | — | — | US | claimed |
| US-6703216-B2 | AN OXIDIZED COFACTOR FOR THE FIRST OXIDOREDUCTASE THAT IS REDUCED UPON OXIDATION OF GHB BY THE FIRST OXIDOREDUCTASE IS IN TURN OXIDIZED BY ANOTHER OXIDOREDUCTASE CAUSING DETECTABLE CONVERSION OF CHROMOGEN OR DYE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2004-03-09 | — | — | US | claimed |
| US-20030175846-A1 | Methods, compositions and apparatuses for detection of gamma-hydroxybutyric acid (GHB) | REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE | 2003-09-18 | — | — | US | claimed |
| EP-1294922-A2 | METHOD FOR TREATING CANCER, VISUALIZING CELL STRUCTURES, AND ISOLATING ORGANELLES USING ORGANELLE CRYSTALLIZING AGENTS | Kong, Qingzhong (US) | 2003-03-26 | — | — | EP | claimed |
| US-20020143042-A1 | Method and composition for treating cancer using cellular organelle crystallizing agents | KONG QINGZHONG (US) | 2002-10-03 | — | — | US | claimed |
| US-20020086345-A1 | Methods and compositions for the visualization of cellular organelles using tetrazolium salts | KONG QINGZHONG (US) | 2002-07-04 | — | — | US | claimed |
| US-6376525-B1 | Tetrazolium salts and derivatives, preferably tetrazolium red and tetrazolium violet, in combination with chemotherapeutic agents delivered in a polylactic acid carrier; noninvasive antitumor treatments | KONG QINGZHONG (US) | 2002-04-23 | — | — | US | claimed |
| US-6368818-B1 | VISUAL AIDS AND CANCER TREATMENT | KONG QINGZHONG (US) | 2002-04-09 | — | — | US | claimed |
| WO-2001082780-A2 | METHOD FOR TREATING CANCER, VISUALIZING CELL STRUCTURES, AND ISOLATING ORGANELLES USING ORGANELLE CRYSTALLIZING AGENTS | KONG QINGZHONG (US) | 2001-11-08 | — | — | WO | claimed |
| EP-0971037-A2 | Stable reagent for formazan-based assay | Kirkegaard & Perry Laboratories, Inc. (US) | 2000-01-12 | — | — | EP | claimed |
| US-4892817-A | INDOXYL PHOSPHATE, TETRAZOLIUM SALT, AND WATER SOLUBLE FERRICYANIDE FERROCYANIDE SALT | BIOGENEX LABORATORIES (US) | 1990-01-09 | — | — | US | claimed |
| EP-2928891-B1 | PROTEIN KINASE C INHIBITORS AND USES THEREOF | RIGEL PHARMACEUTICALS INC (US) | 2019-02-20 | — | — | EP | disclosed |
| EP-0127847-A1 | 7-Oxo-4-thia-1-azabicyclo(3.2.0)hept-2-ene derivatives | HOECHST UK LIMITED (GB) | 1984-12-12 | — | — | EP | disclosed |